(SXI) Standex International - Overview

Sector: Industrials | Industry: Specialty Industrial Machinery | Exchange: NYSE (USA) | Market Cap: 2.970m USD | Total Return: 70.6% in 12m

Sensors, Magnetic Components, Mold Texturizing, Medical Refrigeration
Total Rating 62
Safety 73
Buy Signal -0.47
Specialty Industrial Machinery
Industry Rotation: -8.7
Market Cap: 2.97B
Avg Turnover: 44.4M
Risk 3d forecast
Volatility33.0%
VaR 5th Pctl5.67%
VaR vs Median4.10%
Reward TTM
Sharpe Ratio1.47
Rel. Str. IBD73.1
Rel. Str. Peer Group67.9
Character TTM
Beta1.252
Beta Downside1.444
Hurst Exponent0.388
Drawdowns 3y
Max DD38.01%
CAGR/Max DD0.61
CAGR/Mean DD2.60
EPS (Earnings per Share) EPS (Earnings per Share) of SXI over the last years for every Quarter: "2021-03": 1.19, "2021-06": 1.4, "2021-09": 1.34, "2021-12": 1.45, "2022-03": 1.54, "2022-06": 1.54, "2022-09": 1.6, "2022-12": 1.74, "2023-03": 1.65, "2023-06": 1.76, "2023-09": 1.74, "2023-12": 1.78, "2024-03": 1.75, "2024-06": 1.76, "2024-09": 1.71, "2024-12": 1.91, "2025-03": 1.95, "2025-06": 2.28, "2025-09": 1.99, "2025-12": 2.08, "2026-03": 2.21,
EPS CAGR: 8.91%
EPS Trend: 93.6%
Last SUE: -0.13
Qual. Beats: 0
Revenue Revenue of SXI over the last years for every Quarter: 2021-03: 172.216, 2021-06: 176.435, 2021-09: 175.61, 2021-12: 185.709, 2022-03: 189.281, 2022-06: 184.739, 2022-09: 180.6, 2022-12: 187.789, 2023-03: 184.332, 2023-06: 188.327, 2023-09: 184.774, 2023-12: 178.4, 2024-03: 177.267, 2024-06: 180.194, 2024-09: 170.464, 2024-12: 189.814, 2025-03: 207.78, 2025-06: 222.049, 2025-09: 217.431, 2025-12: 221.32, 2026-03: 224.595,
Rev. CAGR: 6.90%
Rev. Trend: 77.3%
Last SUE: -0.10
Qual. Beats: 0

Warnings

Below Avwap Earnings

Tailwinds

No distinct edge detected

Description: SXI Standex International

Standex International Corporation (NYSE: SXI) is a diversified global manufacturer operating across five primary segments: Electronics, Engineering Technologies, Scientific, Engraving, and Specialty Solutions. The company produces a broad range of technical components, including reed relays, sensors, and transformers, alongside specialized services such as mold texturizing and aerospace metal forming. Its portfolio supports critical infrastructure in the aviation, defense, medical, and energy sectors.

The company operates an industrial conglomerate business model, which seeks to mitigate cyclical downturns by maintaining exposure to uncorrelated end markets. In the industrial machinery sector, this diversification is often used to balance the long-cycle nature of aerospace and defense contracts with the shorter-cycle demand of commercial electronics and scientific refrigeration. Standex utilizes a bolt-on acquisition strategy to expand its brand portfolio, which currently includes names such as Spincraft, Federal, and Standex-Meder.

Investors looking for deeper insights into these operational segments may find ValueRay’s comparative data useful for further analysis. Founded in 1955 and headquartered in New Hampshire, Standex maintains a global footprint with manufacturing and service capabilities designed for high-precision, low-volume industrial applications.

Headlines to Watch Out For
  • Electronics segment expansion driven by electric vehicle and renewable energy demand
  • Strategic acquisitions accelerate high-margin specialty solutions and scientific equipment growth
  • Aerospace and defense spending boosts engineering technologies segment order backlogs
  • Raw material costs and global supply chain disruptions impact manufacturing margins
  • Industrial production cycles influence demand for hydraulic and metal spinning services
Piotroski VR-10 (Strict) 6.5
Net Income: 99.0m TTM > 0 and > 6% of Revenue
FCF/TA: 0.04 > 0.02 and ΔFCF/TA 1.08 > 1.0
NWC/Revenue: 36.63% < 20% (prev 45.95%; Δ -9.32% < -1%)
CFO/TA 0.05 > 3% & CFO 79.6m > Net Income 99.0m
Net Debt (454.8m) to EBITDA (178.9m): 2.54 < 3
Current Ratio: 3.05 > 1.5 & < 3
Outstanding Shares: last quarter (12.1m) vs 12m ago 0.02% < -2%
Gross Margin: 39.81% > 18% (prev 0.39%; Δ 3.94k% > 0.5%)
Asset Turnover: 57.47% > 50% (prev 48.13%; Δ 9.34% > 0%)
Interest Coverage Ratio: 4.21 > 6 (EBITDA TTM 178.9m / Interest Expense TTM 33.2m)
Altman Z'' 6.06
A: 0.21 (Total Current Assets 482.7m - Total Current Liabilities 158.4m) / Total Assets 1.53b
B: 0.79 (Retained Earnings 1.20b / Total Assets 1.53b)
C: 0.09 (EBIT TTM 139.6m / Avg Total Assets 1.54b)
D: 1.43 (Book Value of Equity 1.04b / Total Liabilities 728.4m)
Altman-Z'' = 6.06 = AAA
Beneish M -3.18
DSRI: 0.67 (Receivables 179.7m/228.3m, Revenue 885.4m/748.3m)
GMI: 0.98 (GM 39.81% / 39.21%)
AQI: 0.98 (AQ_t 0.55 / AQ_t-1 0.56)
SGI: 1.18 (Revenue 885.4m / 748.3m)
TATA: 0.01 (NI 99.0m - CFO 79.6m) / TA 1.53b)
Beneish M = -3.18 (Cap -4..+1) = AA
What is the price of SXI shares?

As of May 25, 2026, the stock is trading at USD 252.36 with a total of 91,334 shares traded.
Over the past week, the price has changed by +2.87%, over one month by -6.29%, over three months by +5.46% and over the past year by +70.58%.

Is SXI a buy, sell or hold?

Standex International has received a consensus analysts rating of 4.40. Therefore, it is recommended to buy SXI.

  • StrongBuy: 2
  • Buy: 3
  • Hold: 0
  • Sell: 0
  • StrongSell: 0

What are the forecasts/targets for the SXI price?
Analysts Target Price 290.8 15.2%
Standex International (SXI) - Fundamental Data Overview as of 21 May 2026
P/E Trailing = 29.8599
P/E Forward = 26.5957
P/S = 3.3544
P/B = 3.9949
P/EG = 0.9516
Revenue TTM = 885.4m USD
EBIT TTM = 139.6m USD
EBITDA TTM = 178.9m USD
Long Term Debt = 472.8m USD (from longTermDebt, last quarter)
Short Term Debt = 11.1m USD (from shortTermDebt, last fiscal year)
Debt = 558.5m USD (from shortLongTermDebtTotal, last quarter) + Leases 49.1m
Net Debt = 454.8m USD (calculated: Debt 558.5m - CCE 103.7m)
Enterprise Value = 3.42b USD (2.97b + Debt 558.5m - CCE 103.7m)
Interest Coverage Ratio = 4.21 (Ebit TTM 139.6m / Interest Expense TTM 33.2m)
EV/FCF = 63.10x (Enterprise Value 3.42b / FCF TTM 54.3m)
FCF Yield = 1.58% (FCF TTM 54.3m / Enterprise Value 3.42b)
FCF Margin = 6.13% (FCF TTM 54.3m / Revenue TTM 885.4m)
Net Margin = 11.18% (Net Income TTM 99.0m / Revenue TTM 885.4m)
Gross Margin = 39.81% ((Revenue TTM 885.4m - Cost of Revenue TTM 533.0m) / Revenue TTM)
Gross Margin QoQ = 38.98% (prev 39.67%)
Tobins Q-Ratio = 2.24 (Enterprise Value 3.42b / Total Assets 1.53b)
Interest Expense / Debt = 5.94% (Interest Expense 33.2m / Debt 558.5m)
Taxrate = 16.98% (14.0m / 82.7m)
NOPAT = 115.9m (EBIT 139.6m * (1 - 16.98%))
Current Ratio = 3.05 (Total Current Assets 482.7m / Total Current Liabilities 158.4m)
Debt / Equity = 0.74 (Debt 558.5m / totalStockholderEquity, last quarter 754.2m)
Debt / EBITDA = 2.54 (Net Debt 454.8m / EBITDA 178.9m)
Debt / FCF = 8.38 (Net Debt 454.8m / FCF TTM 54.3m)
Total Stockholder Equity = 718.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.42% (Net Income 99.0m / Total Assets 1.53b)
RoE = 13.78% (Net Income TTM 99.0m / Total Stockholder Equity 718.4m)
RoCE = 11.72% (EBIT 139.6m / Capital Employed (Equity 718.4m + L.T.Debt 472.8m))
RoIC = 9.01% (NOPAT 115.9m / Invested Capital 1.29b)
WACC = 9.53% (E(2.97b)/V(3.53b) * Re(10.39%) + D(558.5m)/V(3.53b) * Rd(5.94%) * (1-Tc(0.17)))
Discount Rate = 10.39% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 73.33 | Cagr: 0.76%
[DCF] Terminal Value 74.26% ; FCFF base≈47.9m ; Y1≈54.9m ; Y5≈80.9m
[DCF] Fair Price = 45.67 (EV 1.01b - Net Debt 454.8m = Equity 553.2m / Shares 12.1m; r=9.53% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 93.56 | EPS CAGR: 8.91% | SUE: -0.13 | # QB: 0
Revenue Correlation: 77.28 | Revenue CAGR: 6.90% | SUE: -0.10 | # QB: 0
EPS next Quarter (2026-09-30): EPS=2.17 | Chg30d=-4.93% | Revisions=-20% | Analysts=4
EPS current Year (2026-06-30): EPS=8.66 | Chg30d=-2.49% | Revisions=-43% | GrowthEPS=+8.6% | GrowthRev=+12.6%
EPS next Year (2027-06-30): EPS=9.96 | Chg30d=-4.81% | Revisions=+14% | GrowthEPS=+15.0% | GrowthRev=+5.9%
[Analyst] Revisions Ratio: -43%